|
Selpercatinib Clinical Trials
3 actively recruiting trials across 1 location
Also known as: Retevmo, Retsevmo
Other2 trials
Washington D.C., District of Columbia1 trial
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
MedStar Washington Hospital Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.